detinfДЕТСКИЕ ИНФЕКЦИИCHILDREN INFECTIONS2072-81072618-8139Association of Pediatricians and Infection Disease doctors10.22627/2072-8107-2019-18-1-22-28detinf-403Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEW OF THE LITERATUREПарвовирусная инфекция у детейParvovirus infection in childrenhttps://orcid.org/0000-0003-1050-9081АнохинВ. А.AnokhinV. A.

Анохин Владимир Алексеевич - доктор медицинских наук, профессор, заведующий кафедрой детских инфекций КГМУ, главный детский инфекционист МЗ РТ.

Vladimir Anokhin - MD, Professor, Head of childhood infections

anokhin56@maii.ruhttps://orcid.org/0000-0001-9394-5879СабитоваА. М.SabitovaA. M.

Сабитова Альфия Махмутовна - кандидат медицинских наук, ассистент кафедры детских инфекций КГМУ.

Казань

TatianaAglyamova

sabitova00@mail.ruhttps://orcid.org/0000-0001-9336-4820АглямоваТ. А.AglyamovaT. A.

Аглямова Татьяна Александровна - врач-инфекционист, заместитель главного врача по медицинской части.

Набережные Челны

TatianaAglyamova

tagl@yandex.ruhttps://orcid.org/0000-0002-8430-1876МинаеваЕ. Ю.MinaevaE. Y.

Минаева Елена Юрьевна - врач-инфекционист, заведующая отделением нейроинфекций.

ElenaMinaeva

sofpal@mail.ruhttps://orcid.org/0000-0003-4480-7060МарченковаН. А.MarchenkovaN. A.

Марченкова Нина Александровна - врач-инфекционист, ординатор отделениянейроинфекций.

Nina Marchenkova

marchenkovana@mail.ruhttps://orcid.org/0000-0002-7164-4554КнязеваО. Ю.KnyazevaO. Y.

Князева Оксана Юрьевна - врач-лаборант, заведующая лабораторией, Набережночелнинская инфекционная больница

Oksana Knyazeva

bio-oksy@yandex.ruКазанский государственный медицинский университетРоссияKazan State Medical UniversityRussian FederationГосударственное автономное учреждение здравоохранения «Набережночелнинская инфекционная больница»РоссияNaberezhnyeChelny Hospital for Infectious Diseases, Naberezhnye ChelnyRussian Federation2019050420191812228Copyright © Анохин В.А., Сабитова А.М., Аглямова Т.А., Минаева Е.Ю., Марченкова Н.А., Князева О.Ю., 20192019Анохин В.А., Сабитова А.М., Аглямова Т.А., Минаева Е.Ю., Марченкова Н.А., Князева О.Ю.Anokhin V.A., Sabitova A.M., Aglyamova T.A., Minaeva E.Y., Marchenkova N.A., Knyazeva O.Y.This work is licensed under a Creative Commons Attribution 4.0 License.https://detinf.elpub.ru/jour/article/view/403

В обзорной статье представлены современные сведения по этиологии, эпидемиологии, клинических проявлениях парвовирус-ной инфекции у детей. Рассмотрены вопросы использования лабораторных методов исследования, лечения и профилактики инфекции.

The article presents current information about the etiology, epidemiology, clinical manifestations of parvovirus infection in children. The problems of the use of laboratory tests, treatment and prevention ofinfection.

парвовирусная инфекциядетиэтиологияэпидемиологияклиническая картинапринципы диагностикилечениеparvovirus infectionchildrenetiologyepidemiologyclinical presentationprinciples of diagnosistreatmentReferencesSerjeant G.R., Topley J.M., Mason K., Serjeant B.E., Pattison J.R., Jones S.E., Mohamed R. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981: 595-597.Serjeant G.R., Topley J.M., Mason K., Serjeant B.E., Pattison J.R., Jones S.E., Mohamed R. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981: 595-597.Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L.R., Cohen BJ., Mortimer P.P., Pereira M.S. Human parvovirus, the cause of erithema infectiosum (fifth disease). Lancet. 1983; 321: 1378.Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L.R., Cohen BJ., Mortimer P.P., Pereira M.S. Human parvovirus, the cause of erithema infectiosum (fifth disease). Lancet. 1983; 321: 1378.Cossart Y.E., Field A.M., Cаnt B., Widdows D. Parvovius-like particles in human sera. Lancet. 1975; 1 (7898): 72-73.Cossart Y.E., Field A.M., Cаnt B., Widdows D. Parvovius-like particles in human sera. Lancet. 1975; 1 (7898): 72-73.Rationalization and extension of the taxonomy of the family Parvo-viridae. ICTVon-line. Code assigned: 2013.001a-aaaV: 23-24.Rationalization and extension of the taxonomy of the family Parvo-viridae. ICTVon-line. Code assigned: 2013.001a-aaaV: 23-24.Huschen J.M., Mihneva Z., Mentis A.F., Schneider F., Aboudy Y, Grossman Z., Rudich H., Kasymbekova K., Sarv I., Nedeljkovic J., Tahita M.C., Tarnagda Z., Ouedraogo J.-B., Gerasimova A.G., Moskaleva T.N., Tikhonova N.T., Chitadze N., Forbi J.C., Faneye A.O., Otegbayo J.A., Charpentier E., Muller C.P. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009; 47(11): 3735-3738.Huschen J.M., Mihneva Z., Mentis A.F., Schneider F., Aboudy Y, Grossman Z., Rudich H., Kasymbekova K., Sarv I., Nedeljkovic J., Tahita M.C., Tarnagda Z., Ouedraogo J.-B., Gerasimova A.G., Moskaleva T.N., Tikhonova N.T., Chitadze N., Forbi J.C., Faneye A.O., Otegbayo J.A., Charpentier E., Muller C.P. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009; 47(11): 3735-3738.Schneider B., H ne A., Tolba R.H., Fischer Y.-P., Blmel J. Eis-H binger A.M. Simultaneous persistence of multiple genome variants of human parvovirus B19. J. Gen. Virol. 2008; 89: 164-176.Schneider B., H ne A., Tolba R.H., Fischer Y.-P., Blmel J. Eis-H binger A.M. Simultaneous persistence of multiple genome variants of human parvovirus B19. J. Gen. Virol. 2008; 89: 164-176.Toan N.L., Duechting A., Kremsner P.G., Song L.H., Ebinger M., Ab-erle S., Binh V.Q., Duy D.N., Torresi J., Kandolf R., Bock C.-Th. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol. 2006; 87:. 2941-2949.Toan N.L., Duechting A., Kremsner P.G., Song L.H., Ebinger M., Ab-erle S., Binh V.Q., Duy D.N., Torresi J., Kandolf R., Bock C.-Th. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol. 2006; 87:. 2941-2949.Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002; 301:374.Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002; 301:374.Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002; 76:9124.Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002; 76:9124.Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol. 2007; 88:428.Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol. 2007; 88:428.Лаврентьева И.Н., Антипова А.Ю. Парвовирус В19 человека: характеристика возбудителя, распространение и диагностика обусловленной им инфекции. Инфекция и иммунитет. 2013; 3(4): 311-322.Lavrentieva I.N., Antipova A.Yu. Human parvovirus B19: characteristic of the pathogen, distribution and diagnosis of the infection caused by it. Infektsiya i Immunitet=Infection and Immunity. 2013; 3 (4): 311-322. (In Russ.)Mortimer P.P. , Humphries R.K., Moore J.G., Purcell R.H., Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 1983; 302:426.Mortimer P.P. , Humphries R.K., Moore J.G., Purcell R.H., Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 1983; 302:426.Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993; 262:1 14.Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993; 262:1 14.Brown K.E., Hibbs J.R., Gallinella G., Anderson S.M., Lehman E.D., McCarthy P., Young N.S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994; 330:1192.Brown K.E., Hibbs J.R., Gallinella G., Anderson S.M., Lehman E.D., McCarthy P., Young N.S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994; 330:1192.Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 in-tegrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta 1 integrin for viral entry. Blood. 2003; 102:3927.Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 in-tegrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta 1 integrin for viral entry. Blood. 2003; 102:3927.Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J, Kodera T, Ishii T., Hirabayashi Y., Koyanagi Y., Sasaki T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood. 2005; 106: 3449.Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J, Kodera T, Ishii T., Hirabayashi Y., Koyanagi Y., Sasaki T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood. 2005; 106: 3449.Yamashita K., Matsunaga Y., Taylor-Wiedeman J., Yamazaki S. A significant age shift of the human parvovirus B1 9 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med SciBiol. 1992; 45:49.Yamashita K., Matsunaga Y., Taylor-Wiedeman J., Yamazaki S. A significant age shift of the human parvovirus B1 9 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med SciBiol. 1992; 45:49.Kerr S., O'Keeffe G., Kilty C., Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol. 1999; 57:179.Kerr S., O'Keeffe G., Kilty C., Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol. 1999; 57:179.Anderson MJ., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152:257.Anderson MJ., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152:257.Тихонова Н.Т., Герасимова А.Г., Москалева Т.Н., Цвиркун О.В., Чава О.О. Оценка распространения парвовирусной инфекции в Москве: Информационное письмо № 11. М.: Департамент здравоохранения Правительства Москвы, 2004:11.Tikhonova N.T., Gerasimova A.G., Moskaleva T.N., Tsvirkun O.V, Chava O.O. Assessment of the spread of parvovirus infection in Moscow: Informational letter №11. Moscow: Moscow Government Health Department, 2004:1 1. (In Russ.)Mossong J., Hens N., Friederichs V, Davidkin I., Broman M., Litwin-ska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology, force of infection, and maternal risk of infection. Epidemiol. Infect. 2008; 1 36(8): 1059-1068.Mossong J., Hens N., Friederichs V, Davidkin I., Broman M., Litwin-ska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology, force of infection, and maternal risk of infection. Epidemiol. Infect. 2008; 1 36(8): 1059-1068.Cartter M.L., Farley T.A., Rosengren S., Quinn D.L., Gillespie S.M., Gary G.W., Hadler J.L. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis. 1991; 163:282.Cartter M.L., Farley T.A., Rosengren S., Quinn D.L., Gillespie S.M., Gary G.W., Hadler J.L. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis. 1991; 163:282.Gay NJ., Hesketh L.M., Cohen B.J., Rush M, Bates C., Morgan-Capner P., Miller E. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 1994; 4:R104.Gay NJ., Hesketh L.M., Cohen B.J., Rush M, Bates C., Morgan-Capner P., Miller E. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 1994; 4:R104.Gratac E., Torres P.J., Vidal J., Antoln E., Costa J., Jimnez de Anta M.T., Cararach V, Alonso P.L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 1995; 171: 1360-1363.Gratac E., Torres P.J., Vidal J., Antoln E., Costa J., Jimnez de Anta M.T., Cararach V, Alonso P.L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 1995; 171: 1360-1363.Harger J.H., Adler S.P., Koch W.C., Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet. Gynecol. 1998; 91: 41 3-420.Harger J.H., Adler S.P., Koch W.C., Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet. Gynecol. 1998; 91: 41 3-420.Kleinman S.H., Glynn S.A., Lee T.H., Tobler L., Montalvo L., Todd D., Kiss J.E., Shyamala V, Busch M.P. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007; 47(10):1756.Kleinman S.H., Glynn S.A., Lee T.H., Tobler L., Montalvo L., Todd D., Kiss J.E., Shyamala V, Busch M.P. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007; 47(10):1756.Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu MY, Busch MP A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood. 2009; 114(17):3677.Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu MY, Busch MP A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood. 2009; 114(17):3677.FDA Biologics Guidances. www. fda. Gov / Biologics Blood Vaccines / GuidanceComplianceRegulatoryinformation/Guidances/ default.htm (Accessed on March 20, 2017).FDA Biologics Guidances. www. fda. Gov / Biologics Blood Vaccines / GuidanceComplianceRegulatoryinformation/Guidances/ default.htm (Accessed on March 20, 2017).Schwarz TF, Wiersbitzky S, Pambor M. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectio-sum. J Med Virol. 1994;43(2):171.Schwarz TF, Wiersbitzky S, Pambor M. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectio-sum. J Med Virol. 1994;43(2):171.Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A.1998; 5(14):8227.Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A.1998; 5(14):8227.Mossong J., Hens N., Friederichs V., Davidkin I., Broman M., Litwinska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology,force of infection, and maternal risk of infection. Epidemiol. Infect.-2008; 136(8):1059-1068.Mossong J., Hens N., Friederichs V., Davidkin I., Broman M., Litwinska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology,force of infection, and maternal risk of infection. Epidemiol. Infect.-2008; 136(8):1059-1068.Матвеев В.А., Прощаева Н.В., Самойлович Е.О., Ермолович М.А. Клинико-лабораторная характеристика В19 парвовирус-ной инфекции. Инфекционные болезни. 2008; 6(3): 33-37.Matveev V.A., Proschaeva N.V., Samoilovich E.O., Ermolovich M.A. Clinical and laboratory characteristics of B19 parvovirus infection. Infektsionnyye Bolezni=Infectious Diseases. 2008; 6(3): 33-37. (In Russ.)Bailey J.M. Parvovirus B19 presenting with severe sepsis in a previously healthy 25-year-old female . J. Am. Board Fam. Med. 2006; 19(3): 317-319.Bailey J.M. Parvovirus B19 presenting with severe sepsis in a previously healthy 25-year-old female . J. Am. Board Fam. Med. 2006; 19(3): 317-319.Young N.S., Brown K.E. Mechanisms of disease: Parvovirus. N. Engl. J. Med. 2004; 350(6): 586-597.Young N.S., Brown K.E. Mechanisms of disease: Parvovirus. N. Engl. J. Med. 2004; 350(6): 586-597.Waldman M., Kopp J.B. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007; 2 Suppl 1 :S47.Waldman M., Kopp J.B. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007; 2 Suppl 1 :S47.Lindblom A, Isa A, Norbeck O, Wolf S., Johansson Bo, Broliden K., Tolfvenstam T. Slow clearance of human parvovirus B19 viremia following acute infection. Clin. Infect. Dis. 2005; 41:1201. DOI: 10.1086/444503.Lindblom A, Isa A, Norbeck O, Wolf S., Johansson Bo, Broliden K., Tolfvenstam T. Slow clearance of human parvovirus B19 viremia following acute infection. Clin. Infect. Dis. 2005; 41:1201. DOI: 10.1086/444503.Молочкова О.В., Н.Ю. Егорова, Н.А. Гусева, О.В. Шамшева. К вопросу дифференциальной диагностики инфекционных экзантем у детей: клинический случай инфекционной эритемы парвовирусной этиологии. Педиатрия. 2019; 98(1):159-164. https://doi.org/10.24110/0031-403X-2019-98-1-159-164Molochkova O.V., N.Yu. Egorova, N.A. Guseva, O.V Shamsheva. To the question of differential diagnosis of infectious exanthema in children: a clinical case of infectious erythema of parvovirus etiology. Pediatrics. 2019; 98(1):159-164. (In Russ.) https://doi.org/10.24110/0031-403X-2019-98-1-159-164Boeck K., Mempel M., Schmidt T., Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis. 1998; 62:271.Boeck K., Mempel M., Schmidt T., Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis. 1998; 62:271.Grilli R., Izquierdo M.J., Farina M.C. «Papular-purpuric» gloves and socks» syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol. 1999; 41:793.Grilli R., Izquierdo M.J., Farina M.C. «Papular-purpuric» gloves and socks» syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol. 1999; 41:793.Oguz F, Akdeniz C, Unuvar E, Kucukbasmaci O., Sidal M. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 2002; 38:358.Oguz F, Akdeniz C, Unuvar E, Kucukbasmaci O., Sidal M. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 2002; 38:358.Wildig J, Michon P, Siba P, Mellombo M., Ura A., Mueller I., Cos-sart Y. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis. 2006; 194:146. DOI: 10.1086/505082.Wildig J, Michon P, Siba P, Mellombo M., Ura A., Mueller I., Cos-sart Y. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis. 2006; 194:146. DOI: 10.1086/505082.Shimamura A., Guinan G. Acquired aplastic anemia. Nathan and Oski's Hematology of Infancy and Childhood, WB Saunders, Philadelphia 2003; 6: 256.Shimamura A., Guinan G. Acquired aplastic anemia. Nathan and Oski's Hematology of Infancy and Childhood, WB Saunders, Philadelphia 2003; 6: 256.Rodis J.F., Quinn D.L., Gary G.W Jr., Anderson LJ., Rosengren S., Cartter M.L., Campbell W.A., Vintzileos A.M. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990; 163:1168.Rodis J.F., Quinn D.L., Gary G.W Jr., Anderson LJ., Rosengren S., Cartter M.L., Campbell W.A., Vintzileos A.M. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990; 163:1168.Шипулин Г.А., Белковская М.Э., Мальмберг О.Л., Шипулина О.Ю., Курцер М.А., Лукаш Е.Н., Гнетецкая В.А., Пиксасова О.В., Тарасова Ю.А. Неиммунная водянка плода: диагностика и тактика. Акушерство и гинекология. 2009; 2: 37—40.Shipulin G.A., Belkovskaya M.E., Malmberg O.L., Shipulina O.Yu., Kurtser M.A., Lukash E.N., Gnetetskaya V.A., Piksasova O.V., Tarasоva Yu.A. Non-immune dropsy of the fetus: diagnosis and tactics. Akusherstvo i Ginekologiya=Obstetrics and Gynecology 2009; 2: 37—40. (In Russ.)Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B1 9 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004; 24:513.Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B1 9 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004; 24:513.Lassen J, Jensen AK, Bager P, et al. Pedersen CB, Panum I., Nar-gaard-Pedersen B., Aaby P., Wohlfahrt J., Melbye M. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. Am J Epidemiol. 2012; 176:803.Lassen J, Jensen AK, Bager P, et al. Pedersen CB, Panum I., Nar-gaard-Pedersen B., Aaby P., Wohlfahrt J., Melbye M. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. Am J Epidemiol. 2012; 176:803.Ergaz Z., Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006; 21:421.Ergaz Z., Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006; 21:421.deHaan T.R., Beersma M.., Oepkes D., de Jong E.P., Kroes A.C., Walther FJ. Parvovirus B1 9 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn. 2007; 27:46.deHaan T.R., Beersma M.., Oepkes D., de Jong E.P., Kroes A.C., Walther FJ. Parvovirus B1 9 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn. 2007; 27:46.Aguiar F.S., Lopes D.P., Bazin A.R. Human parvovirus B19 infection in HIV-positive patients. RevSoc Bras Med Trop. 2001; 34:239.Aguiar F.S., Lopes D.P., Bazin A.R. Human parvovirus B19 infection in HIV-positive patients. RevSoc Bras Med Trop. 2001; 34:239.Heegaard E.D., Schmiegelow K. Serologic study on parvovirus b1 9 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications. J Pediatr.Hema-tol.Oncol. 2002; 24:368.Heegaard E.D., Schmiegelow K. Serologic study on parvovirus b1 9 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications. J Pediatr.Hema-tol.Oncol. 2002; 24:368.Pakkyara A., Jha A., Al. Salmi I., W.A. Siddiqi, Al Rahbi N., A.P. Kurku-lasurya, J. Mohsin Persistent anemia in a kidney transplant recipient with parvovirus B19 infection. Saudi J Kidney Dis Transpl. 2017; 28:1447.Pakkyara A., Jha A., Al. Salmi I., W.A. Siddiqi, Al Rahbi N., A.P. Kurku-lasurya, J. Mohsin Persistent anemia in a kidney transplant recipient with parvovirus B19 infection. Saudi J Kidney Dis Transpl. 2017; 28:1447.Eid AJ., Brown R.A., Patel R., Razonable R.R. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006; 43:40.Eid AJ., Brown R.A., Patel R., Razonable R.R. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006; 43:40.Zerbini M., Gallinella G., Cricca M., Bonvicini F, Musiani M. Diagnostic procedures in B19 infection. Pathol Biol (Paris). 2002; 50: 332—338.Zerbini M., Gallinella G., Cricca M., Bonvicini F, Musiani M. Diagnostic procedures in B19 infection. Pathol Biol (Paris). 2002; 50: 332—338.Butchko A.R., Jordan J.A. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J ClinMicrobiol. 2004; 42:3191.Butchko A.R., Jordan J.A. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J ClinMicrobiol. 2004; 42:3191.Toppinen M, Norja P, Aaltonen LM, S.Wessberg, L. Hedman, M. Soderlund-Venermo, K. Hedman. A new quantitative PCR for human parvovirus B19 genotypes. J Virol Methods. 2015; 218:40. Doi: 10.1016/J.jviromet.2015.03.006.Toppinen M, Norja P, Aaltonen LM, S.Wessberg, L. Hedman, M. Soderlund-Venermo, K. Hedman. A new quantitative PCR for human parvovirus B19 genotypes. J Virol Methods. 2015; 218:40. Doi: 10.1016/J.jviromet.2015.03.006.Cassinotti P., Burtonboy G., Fopp M., Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53:229.Cassinotti P., Burtonboy G., Fopp M., Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53:229.Bonvicini F., Bua G., Manaresi E., Gallinella G. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells. Virus Res. 2016; 220:47.Bonvicini F., Bua G., Manaresi E., Gallinella G. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells. Virus Res. 2016; 220:47.Bonvicini F, Bua G., Conti I., Manaresi E., Gallinella G. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells. Biochem Pharmacol. 2017; 136: 32.Bonvicini F, Bua G., Conti I., Manaresi E., Gallinella G. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells. Biochem Pharmacol. 2017; 136: 32.Crabol Y, Terrier B., Rozenberg F, Pestre V, Legendre C., Hermine O., Montagnier-Petrissans C., Guillevin L., Mouthon L. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013; 56:968.Crabol Y, Terrier B., Rozenberg F, Pestre V, Legendre C., Hermine O., Montagnier-Petrissans C., Guillevin L., Mouthon L. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013; 56:968.Koduri P.R. Parvovirus B19-related anemia in HIV-infected patients. AIDS Patient Care STDS. 2000; 14(1):7.Koduri P.R. Parvovirus B19-related anemia in HIV-infected patients. AIDS Patient Care STDS. 2000; 14(1):7.Chen M.Y., Hung C.C., Fang C.T., Hsieh S.M. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Clin Infec Dis. 2001; 32:1361.Chen M.Y., Hung C.C., Fang C.T., Hsieh S.M. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Clin Infec Dis. 2001; 32:1361.Seng C., Watkins P., Morse D., Barrett S.P., Zambon M., Andrews N., Atkins M., Hall S., Lau Y.K., Cohen BJ. Parvovirus B19 outbreak on an adult ward. Epidemiol Infect. 1994; 11 3:345.Seng C., Watkins P., Morse D., Barrett S.P., Zambon M., Andrews N., Atkins M., Hall S., Lau Y.K., Cohen BJ. Parvovirus B19 outbreak on an adult ward. Epidemiol Infect. 1994; 11 3:345.Garner J.S. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996; 17:53.Garner J.S. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996; 17:53.Chandramouli S., Medina-Selby A., Coit D., Schaefer M., Spencer T., Brito L.A., Zhang P., Otten G., Mandl C.W., Mason P.W., Dormitzer P.R., Settembre E.C. Generation of a parvovirus B19 vaccine candidate. Vaccine. 2013; 31:3872.Chandramouli S., Medina-Selby A., Coit D., Schaefer M., Spencer T., Brito L.A., Zhang P., Otten G., Mandl C.W., Mason P.W., Dormitzer P.R., Settembre E.C. Generation of a parvovirus B19 vaccine candidate. Vaccine. 2013; 31:3872.

The authors declare that there are no conflicts of interest present.